United States · FDA National Drug Code directory
VERQUVO
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0006-5029_13b78d9a-fa62-4fcf-8a33-233bc48faccb
- Product NDC
- 0006-5029
- Form
- TABLET, FILM COATED
- Composition / generic term
- vericiguat
- Labeler
- Merck Sharp & Dohme LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20210201
- Source listing expiry
- 20271231
Source-listed ingredients
- VERICIGUAT — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 14 TABLET, FILM COATED in 1 BOTTLE (0006-5029-01) · 0006-5029-01
- 30 TABLET, FILM COATED in 1 BOTTLE (0006-5029-02) · 0006-5029-02
- 10 BLISTER PACK in 1 CARTON (0006-5029-04) / 10 TABLET, FILM COATED in 1 BLISTER PACK (0006-5029-03) · 0006-5029-04
- 1 BOTTLE in 1 CARTON (0006-5029-06) / 14 TABLET, FILM COATED in 1 BOTTLE (0006-5029-05) · 0006-5029-06
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →